drugset / Trial / NCT00571103
Acamprosate in the Treatment of Pathological Gambling
Phase 4
Completed
26 enrolled
University of Iowa
Forest Laboratories · collabUniversity of Nebraska · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see whether acamprosate (Campral) will curb the desire to gamble in people with pathological gambling disorder.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acamprosate | Small molecule | 666 mg | Oral |